Eye tests may predict Alzheimer's before symptoms show

NCT ID NCT07007208

Recruiting now Diagnosis Sponsor: University Hospital, Toulouse Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 17, 2026 · Updated 2 times

Summary

This study looks at whether simple eye-tracking tests and brain scans can detect very early signs of Alzheimer's disease in 100 healthy older adults. Half of the participants carry a genetic risk factor (APOE4). The goal is to find biomarkers that could lead to earlier diagnosis, before memory loss begins.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a simple, non-invasive way to detect Alzheimer's risk years before memory problems start.
What could go wrong: This is an early-phase study with only 100 participants, so results may not apply to everyone. The tests are experimental and not yet proven for diagnosis.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALZHEIMER DISEASE

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

University Hospital of Toulouse
RECRUITING

Toulouse, 31059, France

Contact

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Contact

Contact

Contact

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.